Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
pentamidine isetionate, Quantity: 300 mg
Hospira Australia Pty Ltd
Injection, powder for
Excipient Ingredients:
Intravenous Infusion
300 mg x 1 vial
(S1) This Schedule is intentionally blank
1. As an alternative first line treatment for Pneumocystis carinii Pneumonia/Infection in AIDS patients. 2. As second line treatment for Pneumocystis carinii Pneumonia/Infection in non-AIDS patients; 3. As second line treatment of Leishmaniasis (visceral and cutaneous), except Leishmania aethiopica where it may be used as first line therapy; 4. As second line treatment for Trypanosomiasis (Haemolymphete stage only) (except for the Trypanosomiasis rhodesiense strain due to lack of efficacy).
Visual Identification: White to almost white powder or plug; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Listed (Export Only)
2021-11-08